C
Cardiff Oncology, Inc. (CRDF)
NCM – Real Time Price. Currency in USD
1.25
+0.04 (3.31%)
At close: Jun 26, 2026, 4:00 PM EDT
1.21
-0.04 (-3.19%)
After-hours: Jun 26, 2026, 5:15 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.25
+0.04 (3.31%)
At close: Jun 26, 2026, 4:00 PM EDT
1.21
-0.04 (-3.19%)
After-hours: Jun 26, 2026, 5:15 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $8.5M significantly exceed its total debt $646.0K, ensuring strong financial flexibility
Total current assets $47.3M exceed Total current liabilities $14.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$12.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.27 | 6.05 | 10 | |
| Quick ratio | 3.27 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 386K | 488K | 683K | 593K | 525K |
| Gross Profit | 186K | 90K | 279K | -311K | -372K |
| Operating Income | -40M | -45M | -49M | -49M | -47M |
| Net Income | -39M | -41M | -45M | -46M | -45M |
| EBITDA | -40M | -45M | -48M | -48M | -47M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -48.12 | 43.03 | 5.5 |
| Next quarter | -43.98 | 1.91 | 2.0 |
| Current year | -58.85 | 1.32 | 2.0 |
| Next year | -22.42 | -19.59 | 1.0 |
| Weighted average score | 2.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -83.12 | -71.07 | -63.63 | -105.92 | 1.0 |
| Y/Y | -62.38 | 8.11 | 10 | 3.95 | 4.3 |
| 3y average | 17.74 | -5.85 | 6.92 | -3.62 | 4.0 |
| 5y average | 11.77 | -20.17 | 6.25 | -20.26 | 3.5 |
| Weighted average score | 3.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |